CH Peptides
Every formulation is curated with lab-grade ingredients, and we're syncing up the freshest data from our inventory so you see accurate availability as soon as the app loads.
Loading live inventory
Syncing 24 research sprays
Verifying lab supplies
Supabase + Stripe ready
Orders placed before 2 P.M. PST Monday through Friday are shipped out same day!
Looks like you haven't added any products to your cart yet.
Loading...
AHK-cu, known as Copper Tripeptide-1 or Glycyl-L-histidyl-L-lysine-Cu2+, is a copper-binding peptide tripeptide complex. It has been referred to as GHK-Cu in some literature, derived from sequences similar to pro-collagen fragments but differs in its composition by including a bound copper ion.
The amino acid sequence for AHK-cu is H-Gly-His-Lys-OH with a Cu2+ ion chelated to the histidine residue. It consists of three amino acids, with the histidine facilitating copper binding. Specific structural modifications include the formation of a stable complex with copper, contributing to its biological activity through redox reactions.
AHK-cu interacts with cellular pathways involving matrix metalloproteinases (MMPs) and fibroblast growth factors. It indirectly influences pathways such as MAPK/ERK to promote wound healing and tissue remodeling but does not directly bind to classical receptors like GLP-1R or β3-AR. The exact pharmacological action includes modulation instead of traditional agonist or antagonist activity, primarily due to its copper-binding capacity.
AHK-cu is soluble in water at concentrations sufficient for biochemical investigations, typically recommended at reconstitution concentrations between 0.2-1 mg/mL. Stability has been maintained in lyophilized form at room temperature for extended durations, while reconstituted peptide should be used promptly or stored at -20°C to -80°C to maintain activity.
For laboratory research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or preventive applications.
AHK-cu, known as Copper Tripeptide-1 or Glycyl-L-histidyl-L-lysine-Cu2+, is a copper-binding peptide tripeptide complex. It has been referred to as GHK-Cu in some literature, derived from sequences similar to pro-collagen fragments but differs in its composition by including a bound copper ion.
The amino acid sequence for AHK-cu is H-Gly-His-Lys-OH with a Cu2+ ion chelated to the histidine residue. It consists of three amino acids, with the histidine facilitating copper binding. Specific structural modifications include the formation of a stable complex with copper, contributing to its biological activity through redox reactions.
AHK-cu interacts with cellular pathways involving matrix metalloproteinases (MMPs) and fibroblast growth factors. It indirectly influences pathways such as MAPK/ERK to promote wound healing and tissue remodeling but does not directly bind to classical receptors like GLP-1R or β3-AR. The exact pharmacological action includes modulation instead of traditional agonist or antagonist activity, primarily due to its copper-binding capacity.
AHK-cu is soluble in water at concentrations sufficient for biochemical investigations, typically recommended at reconstitution concentrations between 0.2-1 mg/mL. Stability has been maintained in lyophilized form at room temperature for extended durations, while reconstituted peptide should be used promptly or stored at -20°C to -80°C to maintain activity.
For laboratory research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or preventive applications.
Chorionic Gonadotropin; commonly abbreviated as HCG. It is a glycoprotein hormone composed of alpha and beta subunits, predominantly characterized in human pregnancy. No specific research codes or development codes are associated with the basic glycoprotein.
HCG is a heterodimeric protein composed of two non-covalently linked subunits: the alpha subunit (92 amino acids) shared with other hormones like LH, FSH, and TSH, and the beta subunit (145 amino acids) which is unique to HCG. The beta subunit contains distinct segments: H-Trp-Met-Ser-Glu-His-Ile-Thr-Arg-Tyr-Leu-... and features specific disulfide bridges essential for activity and stability.
HCG acts as an agonist to the luteinizing hormone/chorionic gonadotropin receptor (LHCG receptor). Binding of HCG to its receptor activates pathways such as the cAMP/PKA signaling cascade, promoting steroidogenesis. EC50 values are variable based on assay and cellular system but are indicative of potent agonist activity.
HCG is soluble in sterile water at concentrations of 1mg/mL for research applications. Upon reconstitution, the solution must be stored at 2-8°C and is stable for up to 24 hours. Lyophilized HCG remains stable at -20°C until reconstitution.
For laboratory research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or preventive applications.
Retatrutide is referred to by its research code LY3502970. As of current knowledge, alternative naming conventions in the literature have not been extensively established.
Retatrutide is a peptide compound consisting of 39 amino acids. The exact amino acid sequence is: H-Thr-Lys-Asp-Glu-Leu-Gln-Ala-Ile-Arg-Trp-Leu-Lys-His-Glu-Arg-Asp-His-Gly-Ile-Lys-Lys-Glu-Cys-Leu-Glu-Glu-Val-Leu-Asp-Ser-Leu-Ala-Arg-Ala-Glu-Glu-Arg-OH. Specific modifications include N-terminal acetylation and C-terminal amidation to enhance its activity and stability. It is structurally designed to interact with multiple peptide receptors.
Retatrutide acts as an agonist at multiple receptors, including the GLP-1 receptor (GLP-1R) and the GIP receptor (GIPR), exhibiting multifaceted activity. Its mechanism enhances several intracellular signaling pathways, notably the cAMP/PKA and PI3K/Akt cascades. It demonstrates a unique binding profile, combining activities that influence metabolic pathways associated with glucose and lipid handling.
Retatrutide is notably soluble in sterile water at a concentration of 1mg/mL. For research applications, it is recommended to reconstitute the lyophilized form in an appropriate buffer and store it at -20°C to maintain stability. Once reconstituted, it remains stable for up to 3 weeks if stored under proper conditions.
For laboratory research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or preventive applications.
Retatrutide is referred to by its research code LY3502970. As of current knowledge, alternative naming conventions in the literature have not been extensively established.
Retatrutide is a peptide compound consisting of 39 amino acids. The exact amino acid sequence is: H-Thr-Lys-Asp-Glu-Leu-Gln-Ala-Ile-Arg-Trp-Leu-Lys-His-Glu-Arg-Asp-His-Gly-Ile-Lys-Lys-Glu-Cys-Leu-Glu-Glu-Val-Leu-Asp-Ser-Leu-Ala-Arg-Ala-Glu-Glu-Arg-OH. Specific modifications include N-terminal acetylation and C-terminal amidation to enhance its activity and stability. It is structurally designed to interact with multiple peptide receptors.
Retatrutide acts as an agonist at multiple receptors, including the GLP-1 receptor (GLP-1R) and the GIP receptor (GIPR), exhibiting multifaceted activity. Its mechanism enhances several intracellular signaling pathways, notably the cAMP/PKA and PI3K/Akt cascades. It demonstrates a unique binding profile, combining activities that influence metabolic pathways associated with glucose and lipid handling.
Retatrutide is notably soluble in sterile water at a concentration of 1mg/mL. For research applications, it is recommended to reconstitute the lyophilized form in an appropriate buffer and store it at -20°C to maintain stability. Once reconstituted, it remains stable for up to 3 weeks if stored under proper conditions.
For laboratory research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or preventive applications.